Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diosmin for Mild to Moderate Ulcerative Colitis
NCT05626166Phase 3Unknown
- Sponsor
- Tanta University
- Start
- Dec 2022
- Primary completion
- Nov 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diosmin in ulcerative colitis (UC), sponsored by Tanta University. Status: unknown.
02
Drugs
diosmin
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT05626166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05626166.